American Century Companies’s Novavax NVAX Stock Holding History

American Century Companies’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,740	Closed	-$535K	–	2339
2021 Q4	$535K	Sell	3,740 -6,265	-63%	-$1.08M	﹤0.01%	1899
2021 Q3	$2.07M	Buy	10,005 +4,719	+89%	+$1.04M	﹤0.01%	1300
2021 Q2	$1.12M	Sell	5,286 -31,812	-86%	-$5.83M	﹤0.01%	1498
2021 Q1	$6.73M	Buy	37,098 +32,131	+647%	+$6.4M	﹤0.01%	867
2020 Q4	$554K	Hold	4,967	–	–	﹤0.01%	1511
2020 Q3	$538K	Buy	+4,967	New	+$605K	﹤0.01%	1318
2016 Q3	–	Sell	-14,852	Closed	-$2.16M	–	1390
2016 Q2	$2.16M	Sell	14,852 -2,874	-16%	-$329K	﹤0.01%	1014
2016 Q1	$1.83M	Buy	17,726 +12	+0.1%	+$1.29K	﹤0.01%	1015
2015 Q4	$2.97M	Buy	17,714 +3,165	+22%	+$487K	﹤0.01%	955
2015 Q3	$2.06M	Buy	14,549 +3,750	+35%	+$841K	﹤0.01%	1012
2015 Q2	$2.41M	Buy	10,799 +2,089	+24%	+$367K	﹤0.01%	997
2015 Q1	$1.44M	Sell	8,710 -1,303	-13%	-$212K	﹤0.01%	1092
2014 Q4	$1.19M	Sell	10,013 -195	-2%	-$20.4K	﹤0.01%	1166
2014 Q3	$851K	Buy	+10,208	New	+$923K	﹤0.01%	1210

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies's NVAX Position: Q1 2022 in Review

American Century Companies sold out of Novavax (NVAX) in Q1 2022, closing a stake of 3,740 shares — an estimated $535K sold.

American Century Companies first reported a position in NVAX in Q3 2014 and held it in 14 quarters. The position peaked at $6.73M in Q1 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

American Century Companies reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
American Century Companies sold 3,740 Novavax shares in Q1 2022, an estimated $535K.
American Century Companies first reported a position in Novavax in Q3 2014 and held it in 14 quarters.
American Century Companies's Novavax position peaked at $6.73M in Q1 2021.
382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on American Century Companies's 13F filing for Q1 2022, filed 11 May 2022.